The reversal of extrapyramidal side effects with SCH 39166, a dopamine D1 receptor antagonist.
Schering-Plough Research, Bloomfield, NJ 07003.
D
D
McHugh
V
V
Coffin
D000818:Animals; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy*; D001552:Benzazepines / Q000627:therapeutic use*; D002428:Cebus; D018492:Dopamine Antagonists; D005260:Female; D006220:Haloperidol / Q000633:toxicity; D017447:Receptors, Dopamine D1
D014150:Antipsychotic Agents; D001552:Benzazepines; D018492:Dopamine Antagonists; D017447:Receptors, Dopamine D1; C058081:ecopipam; D006220:Haloperidol